• Usa, Fauci: "There will be a decision on the Johnson & Johnson vaccine by Friday"

  • Covid-19, Ema green light for the Johnson & Johnson vaccine: "Rare events, more benefits than risks"

  • Production of the Johnson & Johnson vaccine in Baltimore blocked

  • Johnson & Johnson, Ema's opinion is awaited today

  • Aifa committee meeting on Johnson & Johnson vaccine today

Share

April 24, 2021

Green light in the United States for the resumption of distribution and administration of the Johnson & Johnson vaccine. The Food and Drug Administration and the CDC, federal health centers, have accepted the recommendation made by the panel of experts who had advised to lift the embargo on the J&J vaccine after the problems related to manufacturing in Maryland. The go-ahead from the commission came in the afternoon with ten votes in favor and four against. 

From today, Saturday, the single doses will be available again, but with a novelty compared to the past: accepting the "recommendation" of the panel of experts of the health authorities, the Centers for Disease Control and Prevention (Cdc), the federal drug agency will update the product instructions, warning of the risk of thrombosis for women under fifty.



Immunizations had been suspended after some rare cases of blood clots. Of the fifteen cases associated with the J&J vaccine, thirteen involved women between the ages of 18 and 49. The recommendation to resume vaccination came in the afternoon from the CDC commission, at the end of a vote that ended with 10 yes and 4 no. The health authorities, in advising the go-ahead, had explained that the "the benefits outweighed the risks. "